Psychological Treatments for Scleroderma

Completed · Phase 2

Conditions studied: Pain, Depression, Scleroderma, Systemic Sclerosis

In brief

This study will examine the effectiveness of two psychological treatment approaches designed to help people who have scleroderma with three important areas of daily living: pain, depression, and distress about changes in appearance. The study will also evaluate the impact of depression on the two psychological treatments. Because psychological approaches requiring a trained professional can be expensive and are often not available to most patients, this study will also look at the effectiveness of a self-help treatment approach.

Key facts

Study ID

NCT00007267

Run by

Johns Hopkins University

People needed

89

Starts

2001-06-01

Expected to finish

2006-06-01

Last updated by the study team

2017-08-09

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of CREST or systemic sclerosis
• Short-Form McGill Pain Questionnaire score 6 or higher
• Satisfaction with Appearance score of 15 or higher
• Beck Depression score of 10 or higher

You may not qualify if…

• Patients reporting severe depression with suicidal ideation
• Delirium, dementia, or cognitive impairment (Mini Mental State Examination (MMSE) < 24))
• Terminal illness with a life expectancy of less than 1 year

Where it is running

• Johns Hopkins Bayview Medical Center — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.